関連する実験動画
Updated: Jun 23, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
妊娠糖尿病の流行病学と管理
Arianne Sweeting1, Wesley Hannah2, Helena Backman3
1Department of Endocrinology, Royal Prince Alfred Hospital and University of Sydney, Sydney, NSW, Australia.
Lancet (London, England)
|June 23, 2024
まとめ
妊娠中の糖尿病の14%は 早期診断と治療が必要です 妊娠初期糖尿病の早期発見と介入は 妊娠の結果を改善し 合併症を軽減します
科学分野:
- 産婦人科
- 内分泌学
- 公衆衛生
背景:
- 妊娠中の糖尿病 (GDM) は,世界的に約14%の妊娠に影響します.
- 肥満と2型糖尿病 (糖尿病の流行) に関する増加
- 高血圧症や新生児の合併症を含む,重大な直接的な費用と不良な妊娠結果と関連しています.
研究 の 目的:
- 診断のタイミングとサブタイプに基づいてGDMの異質性を強調する.
- 精密医療アプローチの必要性を強調する
- 証拠に基づいた予防,診断,治療戦略を提唱する.
主な方法:
- ハイパーグリセミアと不良妊娠結果の研究と,予約妊娠糖尿病の治療 (TOBOGM) 試験を含む,既存の文献と臨床試験データのレビュー.
- 妊娠時期に基づく診断基準と治療効果の分析
- 糖尿病の流行の影響と技術的進歩の検討
主要な成果:
- 妊娠20週前に診断されたGDM (早期GDM) は,後に診断されたGDM (24週から28週まで) よりも劣った妊娠結果と関連しています.
- 特に危険因子のある女性では 早期にGDMを診断し治療することで 利点があることが示されています
- 現在のWHOの診断ガイドライン (2013) は,主に妊娠後半のスクリーニングに焦点を当てています.
結論:
- GDMの"すべてに合った"アプローチは,その異質性のために不十分です.
- 生涯に渡る精密医療戦略は 効果的なGDMの予防,診断,治療に不可欠です
- 早期のGDMに対処し,母親と胎児の結末を改善するために,さらなる研究と更新されたガイドラインが必要です.
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Pathophysiology of Diabetes
919
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
919
Diabetes: Management and Pharmacotherapy
257
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
257
Hypoglycemia and Glucagon
256
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
256
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications
522
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
522

